We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
Cambridge Nutraceuticals develop and sell healthcare supplements that are proven to provide health benefits. Their products ar ecurrently on shelves in a number of the large high street retailers such as Holland & Barrett and Boots.
days to go: Expired investment: £1,077,710
Please watch the video for more information
days to go: Expired investment: £697,266
Please watch the video for more information
days to go: Expired investment: £215,000
e-Patient Network's new platform connects fragmented rare disease communities and markets.
days to go: Expired investment: £649,666
Please watch the video for more information
days to go: Expired investment: £372,996
Please watch the video for more information
days to go: Expired investment: £587,296
Nova Medical Solutions are a manufacturer and supplier of healthcare products and medical consumables. They currently have major clients such as Allied Pharmacies, Primark and the NHS. 
days to go: Expired investment: £310,201
Please watch the video for more information
days to go: Expired investment: £376,618
Farillio is a legal tech company who provide legal solutions and answers for SME’s in an online platform. The platform will provide knowledge jargon free, using how-to video sound bites, checklists, infographics and short easy to read guides.
days to go: Expired investment: £162,528
Robust online validation software providing an evidence trail for digital processes. http://comprobo.co.uk/ 
days to go: Expired investment: £231,081
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph